CN Stock MarketDetailed Quotes

301257 SMO Clinplus

Watchlist
  • 30.04
  • -0.94-3.03%
Market Closed Dec 4 15:00 CST
2.39BMarket Cap22.52P/E (TTM)

SMO Clinplus Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
Total operating revenue
9.17%593.66M
13.16%394.36M
17.42%184.53M
29.65%760.04M
35.53%543.81M
42.20%348.48M
30.02%157.15M
16.55%586.23M
10.82%401.25M
9.09%245.07M
Operating revenue
9.17%593.66M
13.16%394.36M
17.42%184.53M
29.65%760.04M
35.53%543.81M
42.20%348.48M
30.02%157.15M
16.55%586.23M
10.82%401.25M
9.09%245.07M
Other operating revenue
----
--0
----
33.81%2.79K
----
--2.39K
----
--2.09K
----
--0
Total operating cost
18.09%515.07M
17.06%333.64M
19.23%159.4M
21.13%612.3M
21.19%436.15M
27.31%285.02M
20.33%133.7M
17.86%505.5M
17.66%359.88M
18.88%223.88M
Operating cost
18.20%448.07M
16.31%290.26M
16.27%137.8M
24.09%528.94M
25.27%379.07M
35.19%249.55M
26.03%118.52M
14.65%426.25M
14.15%302.6M
13.48%184.59M
Operating tax surcharges
1.98%3.99M
5.62%2.68M
8.98%1.27M
48.61%5.48M
70.86%3.92M
105.25%2.54M
35.00%1.17M
4.02%3.69M
-8.12%2.29M
-20.58%1.24M
Operating expense
7.73%6.16M
6.59%3.96M
36.14%2.09M
49.27%8.51M
53.82%5.72M
77.93%3.71M
44.68%1.53M
39.35%5.7M
56.12%3.72M
44.72%2.09M
Administration expense
17.94%32.53M
22.88%21.93M
25.06%10.8M
-5.41%41.77M
-12.88%27.58M
-20.82%17.85M
2.08%8.63M
48.97%44.16M
53.80%31.66M
78.57%22.54M
Financial expense
61.64%-2.31M
58.98%-1.95M
59.66%-1.22M
-9.57%-7.16M
-49.83%-6.01M
-245.02%-4.75M
-2,593.52%-3.01M
-383.44%-6.53M
-5,715.54%-4.01M
-1,903.42%-1.38M
-Interest expense (Financial expense)
78.91%358.19K
92.46%256.18K
92.25%132.07K
80.64%323.49K
52.22%200.21K
39.05%133.11K
37.31%68.69K
-33.34%179.08K
-37.18%131.53K
-30.52%95.73K
-Interest Income (Financial expense)
56.07%-2.78M
54.25%-2.25M
55.73%-1.38M
-11.72%-7.62M
-49.42%-6.32M
-221.13%-4.93M
-1,487.03%-3.11M
-294.60%-6.82M
-1,067.39%-4.23M
-499.60%-1.53M
Research and development
2.89%26.61M
3.94%16.75M
26.35%8.66M
7.83%34.75M
9.48%25.87M
8.88%16.12M
0.84%6.86M
52.12%32.23M
53.55%23.63M
46.37%14.8M
Credit Impairment Loss
-120.21%-1.83M
-141.84%-1.77M
400.86%401.6K
-95.04%-2.37M
-11.47%-832.08K
37.36%-731.82K
34.09%-133.48K
28.66%-1.22M
18.25%-746.43K
-41.73%-1.17M
Asset Impairment Loss
19.06%-4.01M
25.48%-2.56M
-102.37%-3.06M
-78.98%-8.33M
-105.83%-4.96M
-142.71%-3.44M
-54.24%-1.51M
-3.59%-4.65M
41.64%-2.41M
63.25%-1.42M
Other net revenue
-56.96%5.03M
-69.51%3.12M
-84.32%1.06M
9,755.22%13.72M
4,874.01%11.69M
1,139.31%10.22M
57,415.99%6.74M
101.95%139.19K
95.86%-244.79K
80.91%-983.4K
Fair value change income
558.85%1.22M
373.10%962.71K
1,291.54%784.37K
-17.44%1.14M
-134.76%-266.45K
---352.51K
---65.83K
--1.38M
--766.47K
----
Invest income
35.24%9.19M
56.32%6.05M
204.32%2.63M
1,724.44%8.82M
821.74%6.8M
561.98%3.87M
300.13%865.05K
63.03%-543.18K
16.97%-941.81K
-22.63%-838.16K
-Including: Investment income associates
-67.47%-816.07K
-12.10%-427.9K
-1.58%-162.1K
54.65%-538.92K
57.41%-487.29K
54.46%-381.71K
63.08%-159.58K
19.12%-1.19M
---1.14M
---838.16K
Asset deal income
-223.05%-60.14K
-147.98%-27.31K
-93.60%5.23K
-36.17%15.37K
-0.82%48.88K
304.45%56.93K
588.61%81.73K
131.32%24.07K
176.30%49.28K
31.21%-27.85K
Other revenue
-95.22%521.4K
-95.74%460.51K
-96.14%289.51K
180.60%14.44M
258.82%10.9M
338.23%10.81M
356.94%7.5M
743.90%5.14M
824.61%3.04M
874.96%2.47M
Operating profit
-29.94%83.62M
-13.36%63.84M
-13.28%26.19M
99.65%161.46M
190.22%119.35M
264.57%73.69M
209.02%30.2M
20.81%80.87M
-18.23%41.12M
-35.16%20.21M
Add:Non operating Income
-71.81%1.52K
141.68%2.45K
1,036.20%2.46K
136.85%9.92K
1,961.50%5.38K
290.26%1.02K
-24,157.80%-262.23
-54.25%4.19K
-93.77%260.93
50.34%260.15
Less:Non operating expense
-78.39%67.5K
-78.47%65.91K
-63.71%1.25K
999.47%436.82K
1,808.36%312.29K
2,741.55%306.21K
19.18%3.46K
-46.25%39.73K
-76.10%16.36K
22,072.88%10.78K
Total profit
-29.81%83.55M
-13.09%63.77M
-13.26%26.19M
99.21%161.03M
189.59%119.05M
263.25%73.38M
209.08%30.19M
20.88%80.84M
-18.16%41.11M
-35.19%20.2M
Less:Income tax cost
-37.76%11.29M
-22.62%8.85M
-29.10%3.45M
212.16%26.3M
526.96%18.14M
1,375.44%11.44M
46,891.10%4.87M
-7.48%8.43M
-53.94%2.89M
-79.80%775.32K
Net profit
-28.39%72.26M
-11.33%54.92M
-10.22%22.74M
86.06%134.73M
164.05%100.91M
218.86%61.94M
159.52%25.33M
25.35%72.41M
-13.04%38.22M
-28.93%19.43M
Net profit from continuing operation
-28.39%72.26M
-11.33%54.92M
-10.22%22.74M
86.06%134.73M
164.05%100.91M
218.86%61.94M
159.52%25.33M
25.35%72.41M
-13.04%38.22M
-28.93%19.43M
Net profit of parent company owners
-28.39%72.26M
-11.33%54.92M
-10.22%22.74M
86.06%134.73M
164.05%100.91M
218.86%61.94M
159.52%25.33M
25.35%72.41M
-13.04%38.22M
-28.93%19.43M
Earning per share
Basic earning per share
-35.12%1.09
-11.65%0.91
-9.52%0.38
65.93%2.24
127.03%1.68
151.22%1.03
90.91%0.42
5.47%1.35
-24.49%0.74
-32.79%0.41
Diluted earning per share
-34.94%1.08
-11.76%0.9
-7.32%0.38
66.92%2.22
124.32%1.66
148.78%1.02
86.36%0.41
3.91%1.33
-24.49%0.74
-32.79%0.41
Other composite income
Total composite income
-28.39%72.26M
-11.33%54.92M
-10.22%22.74M
86.06%134.73M
164.05%100.91M
218.86%61.94M
159.52%25.33M
25.35%72.41M
-13.04%38.22M
-28.93%19.43M
Total composite income of parent company owners
-28.39%72.26M
-11.33%54.92M
-10.22%22.74M
86.06%134.73M
164.05%100.91M
218.86%61.94M
159.52%25.33M
25.35%72.41M
-13.04%38.22M
-28.93%19.43M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
Auditor
--
--
--
Lixin Certified Public Accountants (Special General Partnership)
--
--
--
Lixin Certified Public Accountants (Special General Partnership)
--
--
(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022
Total operating revenue 9.17%593.66M13.16%394.36M17.42%184.53M29.65%760.04M35.53%543.81M42.20%348.48M30.02%157.15M16.55%586.23M10.82%401.25M9.09%245.07M
Operating revenue 9.17%593.66M13.16%394.36M17.42%184.53M29.65%760.04M35.53%543.81M42.20%348.48M30.02%157.15M16.55%586.23M10.82%401.25M9.09%245.07M
Other operating revenue ------0----33.81%2.79K------2.39K------2.09K------0
Total operating cost 18.09%515.07M17.06%333.64M19.23%159.4M21.13%612.3M21.19%436.15M27.31%285.02M20.33%133.7M17.86%505.5M17.66%359.88M18.88%223.88M
Operating cost 18.20%448.07M16.31%290.26M16.27%137.8M24.09%528.94M25.27%379.07M35.19%249.55M26.03%118.52M14.65%426.25M14.15%302.6M13.48%184.59M
Operating tax surcharges 1.98%3.99M5.62%2.68M8.98%1.27M48.61%5.48M70.86%3.92M105.25%2.54M35.00%1.17M4.02%3.69M-8.12%2.29M-20.58%1.24M
Operating expense 7.73%6.16M6.59%3.96M36.14%2.09M49.27%8.51M53.82%5.72M77.93%3.71M44.68%1.53M39.35%5.7M56.12%3.72M44.72%2.09M
Administration expense 17.94%32.53M22.88%21.93M25.06%10.8M-5.41%41.77M-12.88%27.58M-20.82%17.85M2.08%8.63M48.97%44.16M53.80%31.66M78.57%22.54M
Financial expense 61.64%-2.31M58.98%-1.95M59.66%-1.22M-9.57%-7.16M-49.83%-6.01M-245.02%-4.75M-2,593.52%-3.01M-383.44%-6.53M-5,715.54%-4.01M-1,903.42%-1.38M
-Interest expense (Financial expense) 78.91%358.19K92.46%256.18K92.25%132.07K80.64%323.49K52.22%200.21K39.05%133.11K37.31%68.69K-33.34%179.08K-37.18%131.53K-30.52%95.73K
-Interest Income (Financial expense) 56.07%-2.78M54.25%-2.25M55.73%-1.38M-11.72%-7.62M-49.42%-6.32M-221.13%-4.93M-1,487.03%-3.11M-294.60%-6.82M-1,067.39%-4.23M-499.60%-1.53M
Research and development 2.89%26.61M3.94%16.75M26.35%8.66M7.83%34.75M9.48%25.87M8.88%16.12M0.84%6.86M52.12%32.23M53.55%23.63M46.37%14.8M
Credit Impairment Loss -120.21%-1.83M-141.84%-1.77M400.86%401.6K-95.04%-2.37M-11.47%-832.08K37.36%-731.82K34.09%-133.48K28.66%-1.22M18.25%-746.43K-41.73%-1.17M
Asset Impairment Loss 19.06%-4.01M25.48%-2.56M-102.37%-3.06M-78.98%-8.33M-105.83%-4.96M-142.71%-3.44M-54.24%-1.51M-3.59%-4.65M41.64%-2.41M63.25%-1.42M
Other net revenue -56.96%5.03M-69.51%3.12M-84.32%1.06M9,755.22%13.72M4,874.01%11.69M1,139.31%10.22M57,415.99%6.74M101.95%139.19K95.86%-244.79K80.91%-983.4K
Fair value change income 558.85%1.22M373.10%962.71K1,291.54%784.37K-17.44%1.14M-134.76%-266.45K---352.51K---65.83K--1.38M--766.47K----
Invest income 35.24%9.19M56.32%6.05M204.32%2.63M1,724.44%8.82M821.74%6.8M561.98%3.87M300.13%865.05K63.03%-543.18K16.97%-941.81K-22.63%-838.16K
-Including: Investment income associates -67.47%-816.07K-12.10%-427.9K-1.58%-162.1K54.65%-538.92K57.41%-487.29K54.46%-381.71K63.08%-159.58K19.12%-1.19M---1.14M---838.16K
Asset deal income -223.05%-60.14K-147.98%-27.31K-93.60%5.23K-36.17%15.37K-0.82%48.88K304.45%56.93K588.61%81.73K131.32%24.07K176.30%49.28K31.21%-27.85K
Other revenue -95.22%521.4K-95.74%460.51K-96.14%289.51K180.60%14.44M258.82%10.9M338.23%10.81M356.94%7.5M743.90%5.14M824.61%3.04M874.96%2.47M
Operating profit -29.94%83.62M-13.36%63.84M-13.28%26.19M99.65%161.46M190.22%119.35M264.57%73.69M209.02%30.2M20.81%80.87M-18.23%41.12M-35.16%20.21M
Add:Non operating Income -71.81%1.52K141.68%2.45K1,036.20%2.46K136.85%9.92K1,961.50%5.38K290.26%1.02K-24,157.80%-262.23-54.25%4.19K-93.77%260.9350.34%260.15
Less:Non operating expense -78.39%67.5K-78.47%65.91K-63.71%1.25K999.47%436.82K1,808.36%312.29K2,741.55%306.21K19.18%3.46K-46.25%39.73K-76.10%16.36K22,072.88%10.78K
Total profit -29.81%83.55M-13.09%63.77M-13.26%26.19M99.21%161.03M189.59%119.05M263.25%73.38M209.08%30.19M20.88%80.84M-18.16%41.11M-35.19%20.2M
Less:Income tax cost -37.76%11.29M-22.62%8.85M-29.10%3.45M212.16%26.3M526.96%18.14M1,375.44%11.44M46,891.10%4.87M-7.48%8.43M-53.94%2.89M-79.80%775.32K
Net profit -28.39%72.26M-11.33%54.92M-10.22%22.74M86.06%134.73M164.05%100.91M218.86%61.94M159.52%25.33M25.35%72.41M-13.04%38.22M-28.93%19.43M
Net profit from continuing operation -28.39%72.26M-11.33%54.92M-10.22%22.74M86.06%134.73M164.05%100.91M218.86%61.94M159.52%25.33M25.35%72.41M-13.04%38.22M-28.93%19.43M
Net profit of parent company owners -28.39%72.26M-11.33%54.92M-10.22%22.74M86.06%134.73M164.05%100.91M218.86%61.94M159.52%25.33M25.35%72.41M-13.04%38.22M-28.93%19.43M
Earning per share
Basic earning per share -35.12%1.09-11.65%0.91-9.52%0.3865.93%2.24127.03%1.68151.22%1.0390.91%0.425.47%1.35-24.49%0.74-32.79%0.41
Diluted earning per share -34.94%1.08-11.76%0.9-7.32%0.3866.92%2.22124.32%1.66148.78%1.0286.36%0.413.91%1.33-24.49%0.74-32.79%0.41
Other composite income
Total composite income -28.39%72.26M-11.33%54.92M-10.22%22.74M86.06%134.73M164.05%100.91M218.86%61.94M159.52%25.33M25.35%72.41M-13.04%38.22M-28.93%19.43M
Total composite income of parent company owners -28.39%72.26M-11.33%54.92M-10.22%22.74M86.06%134.73M164.05%100.91M218.86%61.94M159.52%25.33M25.35%72.41M-13.04%38.22M-28.93%19.43M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ------Unqualified opinion------Unqualified opinion----
Auditor ------Lixin Certified Public Accountants (Special General Partnership)------Lixin Certified Public Accountants (Special General Partnership)----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CN
Overall
Symbol
Latest Price
% Chg

No Data

Investment Theme Finance and Securities Lending
Finance and Securities Lending
Intraday-0.42%
Transferring Securities of Securities
Transferring Securities of Securities
Intraday-0.42%
Innovative Drugs
Innovative Drugs
Intraday-1.77%